International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 6 (November-December 2026) Submit your research before last 3 days of December to publish your research paper in the issue of November-December.

Affordable Healthcare Revolution: How Janaushadhi Kendras Are Redefining Access to Medicines in the Kalyana Karnataka Region

Author(s) Dr. Sharanagoud S Biradar
Country India
Abstract The enduring challenge of ensuring accessible and affordable healthcare across India has been marked by considerable out-of-pocket (OOP) spending on pharmaceutical products, creating substantial barriers to health equity, especially in economically disadvantaged regions. High OOP expenditure, which comprised 47.1% of Total Health Expenditure during 2019-20, has persistently driven millions of households into financial hardship annually, with pharmaceutical costs representing a major proportion of this burden (National Health Accounts, 2020). The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), implemented by the Government of India, seeks to alleviate this financial pressure by supplying quality-assured generic medicines at substantially reduced costs through dedicated retail outlets called Janaushadhi Kendras (JKs) (PMBI, 2025). This investigation examines the transformative contribution of Janaushadhi Kendras toward enhancing pharmaceutical accessibility and reshaping healthcare delivery systems, with particular emphasis on the Kalyana Karnataka region. A mixed-methods research framework was utilized, combining qualitative and quantitative methodologies involving 420 patient participants spanning seven districts. Principal findings reveal that JKs deliver considerable economic advantages, with medication prices ranging from 50-90% below branded alternatives, and patients utilizing JKs reporting average monthly spending of Rs. 540 compared to Rs. 1,120 at private retail pharmacies, representing a 52% cost reduction. The program has achieved notable geographic expansion, with over 16,912 Kendras functioning throughout India as of June 2026 (IBEF, 2025). However, substantial obstacles remain, including limited public awareness (32.6% unfamiliar with the program), distribution inefficiencies, and ongoing skepticism concerning generic medication quality (45.7% uncertain about quality standards). Policy recommendations derived from these results emphasize the necessity for comprehensive awareness initiatives, supply chain enhancement, rigorous quality verification systems, and targeted approaches to increase coverage in underserved communities.
Keywords Keywords: Janaushadhi Kendras; PMBJP; Generic Medicines; Healthcare Access; Out-of-Pocket Expenditure; Kalyana Karnataka; Health Equity; Pharmaceutical Policy
Field Sociology > Administration / Law / Management
Published In Volume 8, Issue 6, November-December 2026
Published On 2026-11-15
DOI https://doi.org/10.36948/ijfmr.2026.v08i06.92048

Share this